The controversy surrounding GlaxoSmithKline's
diabetes drug Avandia mounted Wednesday as a medical expert
prepared to tell lawmakers executives threatened him with legal
action when he first raised questions about the treatment's safety.
Dr. John Buse was contacted by SmithKline Beecham in 1999 after
drawing attention to a trend in heart problems among patients using
Avandia, according to testimony he was prepared to give a House
committee. Buse says the representatives from SmithKline,...Full Story